Z H Liu1, L L Chen, X L Deng, H J Song, Y F Liao, T S Zeng, J Zheng, H Q Li. 1. Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Avenue Jiefang 1277#, Wuhan, Hubei, PR China.
Abstract
AIM: Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine and plays an important role in atherosclerosis of Type 2 diabetes. The aim of this study was to investigate the methylation status of CpG sites in the MCP-1 promoter in Type 2 diabetic patients and its correlation to serum MCP- 1 level, and blood glucose level. METHODS: The 32 patients with Type 2 diabetes and 15 healthy controls were enrolled into the study. Bodymass index, blood pressure, blood lipid, blood glucose, glycosylated hemoglobin (HbA1c), and serum MCP-1 were measured. Genomic DNA was isolated fromthe peripheral blood mononuclear cells (PBMC). Methylation status of CpG sites in theMCP-1 promoter was determined using methylation specific polymerase chain reaction. RESULTS: The promoter region (2890-3050 bp) was predominantly methylated in PBMC from controls.Methylation of CpGmotifs were less methylated in the patients than in the controls (25% vs 80%; p<0.001), while the level of MCP-1 in serum was higher in patients with Type 2 diabetes (193.95±74.96 vs 88.46±55.10; p<0.001). MCP-1 promoter methylation was significantly correlated to serum MCP-1, HbA1c, fasting blood glucose, and triglyceride. CONCLUSION: These data suggest that hypomethylation of CpG sites in the MCP-1 promoter region may be affected by blood glucose and TG, which then increase the serum MCP-1 level and may play a role in the vascular complications of Type 2 diabetes.
AIM: Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine and plays an important role in atherosclerosis of Type 2 diabetes. The aim of this study was to investigate the methylation status of CpG sites in the MCP-1 promoter in Type 2 diabeticpatients and its correlation to serum MCP- 1 level, and blood glucose level. METHODS: The 32 patients with Type 2 diabetes and 15 healthy controls were enrolled into the study. Bodymass index, blood pressure, blood lipid, blood glucose, glycosylated hemoglobin (HbA1c), and serum MCP-1 were measured. Genomic DNA was isolated fromthe peripheral blood mononuclear cells (PBMC). Methylation status of CpG sites in theMCP-1 promoter was determined using methylation specific polymerase chain reaction. RESULTS: The promoter region (2890-3050 bp) was predominantly methylated in PBMC from controls.Methylation of CpGmotifs were less methylated in the patients than in the controls (25% vs 80%; p<0.001), while the level of MCP-1 in serum was higher in patients with Type 2 diabetes (193.95±74.96 vs 88.46±55.10; p<0.001). MCP-1 promoter methylation was significantly correlated to serum MCP-1, HbA1c, fasting blood glucose, and triglyceride. CONCLUSION: These data suggest that hypomethylation of CpG sites in the MCP-1 promoter region may be affected by blood glucose and TG, which then increase the serum MCP-1 level and may play a role in the vascular complications of Type 2 diabetes.
Authors: Katherine Esposito; Francesco Nappo; Francesco Giugliano; Carmen Di Palo; Myriam Ciotola; Michelangela Barbieri; Giuseppe Paolisso; Dario Giugliano Journal: Diabetes Care Date: 2003-05 Impact factor: 19.112
Authors: Ron C Hoogeveen; Alanna Morrison; Eric Boerwinkle; J Shawn Miles; Charles E Rhodes; A Richey Sharrett; Christie M Ballantyne Journal: Atherosclerosis Date: 2005-04-14 Impact factor: 5.162
Authors: E Simeoni; M M Hoffmann; B R Winkelmann; J Ruiz; S Fleury; B O Boehm; W März; G Vassalli Journal: Diabetologia Date: 2004-09-02 Impact factor: 10.122
Authors: B T Yang; T A Dayeh; C L Kirkpatrick; J Taneera; R Kumar; L Groop; C B Wollheim; M D Nitert; C Ling Journal: Diabetologia Date: 2010-11-23 Impact factor: 10.122
Authors: Adiv A Johnson; Kemal Akman; Stuart R G Calimport; Daniel Wuttke; Alexandra Stolzing; João Pedro de Magalhães Journal: Rejuvenation Res Date: 2012-10 Impact factor: 4.663
Authors: Shaoping Zhang; Silvana P Barros; Antonio J Moretti; Ning Yu; Jing Zhou; John S Preisser; Mihai D Niculescu; Steven Offenbacher Journal: J Periodontol Date: 2013-01-31 Impact factor: 6.993